Evidence map›Paper›PMID 42791515›Full record

ArticleInternational journal of emergency medicine2026

Meeting people where they are, whenever they are here: the implementation of harm reduction programs in two U.S. emergency departments.

Karrin Weisenthal, Natalie Strokes, Zoe Weinstein, Samantha Johnson, Glorimar Ruiz-Mercado, Seamus Vahey, James Evans, Jessica L Taylor, Joseph Shay, Laura Welsh and 4 more

Abstract read
In one paragraph

Article in International journal of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Karrin WeisenthalDepartment of Emergency Medicine, Boston Medical Center, One Boston Medical Center Place BCD Building, 4009, Boston, MA, 02118, USA. Karrin.weisenthal@bmc.org.
Natalie StrokesDepartment of Emergency Medicine, Baystate Medical Center, 759 Chestnut Street, Springfield, MA, 01199, USA.
Zoe WeinsteinSection of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Avenue, 6th Floor, Boston, MA, 02119, USA.
Samantha JohnsonSection of Infectious Diseases, Department of Medicine, Boston Medical Center, One Boston Medical Center Place, Boston, MA, 02118, USA.
Glorimar Ruiz-MercadoSection of Infectious Diseases, Department of Medicine, Boston Medical Center, One Boston Medical Center Place, Boston, MA, 02118, USA.
Seamus VaheyBoston University Chobanian & Avedisian School of Medicine, 72 E. Concord St, Boston, MA, 02118, USA.
James EvansSection of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Avenue, 6th Floor, Boston, MA, 02119, USA.
Jessica L TaylorSection of General Internal Medicine, Department of Medicine, Boston Medical Center, 801 Massachusetts Avenue, 6th Floor, Boston, MA, 02119, USA.
Joseph ShaySection of Infectious Diseases, Department of Medicine, Boston Medical Center, One Boston Medical Center Place, Boston, MA, 02118, USA.
Laura WelshDepartment of Emergency Medicine, Massachusetts General Hospital, 5 Emerson Place, Suite 101, Boston, MA, 02114, USA.
Madeline PalmerDepartment of Emergency Medicine, University of Alabama at Birmingham, 521 19th Street South, Suite 203, Birmingham, AL, 35233, USA.
Natalija FarrellDepartment of Emergency Medicine, FAACT Boston Medical Center, One Boston Medical Center Place BCD Building, Boston, MA, 02118, USA.
William E SoaresDepartment of Emergency Medicine, Baystate Medical Center, 759 Chestnut Street, Springfield, MA, 01199, USA.
Elizabeth M SchoenfeldDepartment of Emergency Medicine, Baystate Medical Center, 759 Chestnut Street, Springfield, MA, 01199, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundComplications related to drug use, including overdose, withdrawal, and infection, represent a significant proportion of emergency department (ED) visits in the United States (US). Within addiction medicine, harm reduction focuses on strategies that minimize negative outcomes associated with continued drug use through interventions such as preexposure prophylaxis, naloxone distribution, and safer use supplies. Integration of harm reduction measures into acute care settings may enhance patient trust and engagement in medical care, and may reduce the risk of overdose, viral transmission and serious bacterial infections for patients who use drugs. While there has been an increased interest in incorporation of harm reduction into acute care, data on successful implementation is limited. MAIN BODY: We describe the successful implementation of two unique programs designed to decrease risk and stigma for patients who use drugs and access acute care services in two tertiary care ED's in Massachusetts, US. This article details two different implementation strategies utilized to integrate harm reduction into bedside emergency care. We utilize the CFIR framework to identify barriers and facilitators to successful programmatic implementation, and report on reception by ED teams through post-implementation interviews and program utilization data.

conclusionIntegration of harm reduction into acute care can be safe and feasible. Creating partnerships with community organizations, leadership from an ED champion, and pairing implementation with education for ED staff are key for programmatic success.

Indexed as

Acute careAddiction medicineEmergency medicineHarm reductionHIV preventionImplementation sciencePublic health

Identifiers

PMID42791515
PMCPMC13613606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.